OrthoPediatrics Corp.
OrthoPediatrics Corp. (Nasdaq: KIDS) develops and sells orthopedic implants, surgical instruments, specialized braces and related clinical services for children with orthopedic conditions. Its customers include hospitals, medical facilities, pediatric orthopedic surgeons and patients served by its orthotic and… From the company’s description.
Over the twelve months to Sep 30, 2026, OrthoPediatrics Corp. reported revenue of $264.13M, up 16.1% from a year earlier, and a net loss of $33.88M. Its operating margin was −9.4%, and operations generated $12.49M in cash. In fiscal 2025, it reported revenue of $236.35M, up 15.4% from fiscal 2024, and a net loss of $39.65M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What OrthoPediatrics Corp. does
In the company’s own words
OrthoPediatrics Corp. (Nasdaq: KIDS) develops and sells orthopedic implants, surgical instruments, specialized braces and related clinical services for children with orthopedic conditions. Its customers include hospitals, medical facilities, pediatric orthopedic surgeons and patients served by its orthotic and prosthetic clinics. The company’s 87 surgical and bracing systems address trauma and deformity correction, scoliosis, and sports medicine and other procedures; products include PediLoc, RESPONSE Spine, ApiFix Mid-C, Boston Brace 3D and the Fassier-Duval system. In 2025, trauma and deformity correction generated $166.3 million, or 70% of revenue, while scoliosis contributed $66.0 million, or 28%, and sports medicine and other products contributed $4.0 million, or 2%. OrthoPediatrics uses contract manufacturers for implants and surgical instruments, typically makes its braces in-house, and also operates O&P clinics. Acquisitions have broadened its portfolio and clinic services, including Boston O&P in 2024 and pediatric device businesses acquired in 2020 and 2022. Revenue was $236.3 million in fiscal 2025, and the company had 602 full-time equivalent employees at year-end. Its website is http://www.orthopediatrics.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- WARSAW, IN
- Fiscal year end
- December
- CIK
- 1425450
- SIC
- 3841
Financial performance, year by year
Fiscal 2017–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns OrthoPediatrics Corp. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · OrthoPediatrics Corp.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do OrthoPediatrics Corp. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of OrthoPediatrics Corp.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in OrthoPediatrics Corp.'s last four quarterly filings that the numbers alone won't show?”